Who can participate in the SPRINX-1 Study?
Inclusion Criteria*
-
At least 18 years of age
-
History of radiation treatment or chemoradiotherapy for head and neck cancer for stage 2 or higher
-
Free from recurrence of your cancer and never have had another form of cancer forat least 2 years
-
Suffering from xerostomia and/or hyposalivation and have xerostomia symptoms which were not resolved after treatment for at least 3 months
-
Both parotid glands on imaging examination
Exclusion Criteria*
-
Any active infection
-
Heart failure, reduced kidney function or uncontrolled diabetes (A1c >8%)
-
History of autoimmune diseases known to potentially affect the salivary glands
-
Any malignancy, other than head and neck cancer with the past 3 years except for certain skin and cervical cancers
-
Active smoker or use tobacco products or have a history of substance or alcohol abuse
* Other criteria apply
Why participate in SPRINX-1 Study?
By taking part in this study, you may be helping to make a new treatment for other people suffering from the same disease as yourself.
How many participants are in the study?
This study will include about 42 participants at about up to 5 total clinical sites in the US.
